EMEA-000042-PIP01-07
Key facts
| Active substance |
N-Acetyl-L-Cysteine (corresponds to L-Cysteine), L-Alanine, L-Alanyl-L-Glutamine (corresponds to L-Alanine and L-Glutamine), L-Arginine, Glycine, Glycyl-L-Tyrosine (corresponds to Glycine and L-Tyrosine), L-Histidine, L-Isoleucine, L-Leucine, L-Lysine acetate (corresponds to L-Lysine), LMethionine, L-Phenylalanine, L-Proline, L-Serine, Taurine, L-Threonine, L-Tryptophan, L-Valine
|
| Therapeutic area |
Nutrition
|
| Decision number |
P/175/2009
|
| PIP number |
EMEA-000042-PIP01-07
|
| Pharmaceutical form(s) |
Solution for infusion
|
| Condition(s) / indication(s) |
Supplementation of amino-acids where parenteral nutrition is required.
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Fresenius Kabi Deutschland GmbH
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|